Literature DB >> 16202487

Systemic immune responses in sheep, induced by a novel nano-bead adjuvant.

Jean-Pierre Y Scheerlinck1, Simone Gloster, Anita Gamvrellis, Patricia L Mottram, Magdalena Plebanski.   

Abstract

Although a number of adjuvants are currently approved for use in veterinary species, only alum has been widely used in humans. While it induces strong antibody responses, cell mediated responses are often low and inflammatory reactions at the site of injection are common. We investigated the immunological properties of a novel nano-bead adjuvant in a sheep large-animal model. In contrast to alum, antigen covalently coupled to nano-beads induced substantial cell mediated responses along with moderate humoral responses. No adverse reactions were seen at the site of immunisation in the sheep. Thus, nano-bead adjuvants in veterinary species may be useful for the induction of immunity to viral pathogens, where a cell mediated response is required. These findings also highlight the potential usefulness of nano-bead vaccines for intracellular pathogens in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202487     DOI: 10.1016/j.vaccine.2005.09.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.

Authors:  Lara Vojnov; Alexander T Bean; Eric J Peterson; Maria J Chiuchiolo; Jonah B Sacha; Ferencz S Denes; Matyas Sandor; Deborah H Fuller; James T Fuller; Christopher L Parks; Adrian B McDermott; Nancy A Wilson; David I Watkins
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells.

Authors:  Heidi A Schreiber; Jozsef Prechl; Hongquan Jiang; Alla Zozulya; Zsuzsanna Fabry; Ferencz Denes; Matyas Sandor
Journal:  J Immunol Methods       Date:  2010-02-26       Impact factor: 2.303

3.  Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2 protein from insoluble inclusion body aggregates.

Authors:  Antonino S Cavallaro; Donna Mahony; Margaret Commins; Timothy J Mahony; Neena Mitter
Journal:  Microb Cell Fact       Date:  2011-07-26       Impact factor: 5.328

4.  An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccines.

Authors:  Aiala Salvador; Manoli Igartua; Rosa Maria Hernández; José Luis Pedraz
Journal:  J Drug Deliv       Date:  2011-06-15

5.  Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation.

Authors:  Gérrard Eddy Jai Poinern; Xuan Thi Le; Songhua Shan; Trevor Ellis; Stan Fenwick; John Edwards; Derek Fawcett
Journal:  Int J Nanomedicine       Date:  2011-09-28

6.  Evaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale.

Authors:  Fernanda C Cardoso; Joanne S Roddick; Penny Groves; Denise L Doolan
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

Review 7.  Nanovaccines: recent developments in vaccination.

Authors:  Tarala D Nandedkar
Journal:  J Biosci       Date:  2009-12       Impact factor: 2.795

8.  Small Wonders-The Use of Nanoparticles for Delivering Antigen.

Authors:  Aya Taki; Peter Smooker
Journal:  Vaccines (Basel)       Date:  2015-08-10

Review 9.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

10.  Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation.

Authors:  Donna Mahony; Karishma T Mody; Antonino S Cavallaro; Qiuhong Hu; Timothy J Mahony; Shizhang Qiao; Neena Mitter
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.